Targeting RET-rearranged lung cancers with multikinase inhibitors

Joshua K. Sabari; Evan D. Siau; Alexander Drilon

Targeting RET-rearranged lung cancers with multikinase inhibitors

Joshua K. Sabari
, Evan D. Siau
, Alexander Drilon

Research output: Contribution to journal › Editorial

18 Scopus citations

Original language	English
Pages (from-to)	23-24
Number of pages	2
Journal	Oncoscience
Volume	4
Issue number	3-4
State	Published - 2017

Keywords

BLU-667
Cabozantinib
LOXO-292
Non-small cell lung cancer
RET
RXDX-105
Tyrosine kinase inhibitor
Vandetanib

Cite this

@article{bc068ffd1e844570b5eafe941301249e,

title = "Targeting RET-rearranged lung cancers with multikinase inhibitors",

keywords = "BLU-667, Cabozantinib, LOXO-292, Non-small cell lung cancer, RET, RXDX-105, Tyrosine kinase inhibitor, Vandetanib",

author = "Sabari, \{Joshua K.\} and Siau, \{Evan D.\} and Alexander Drilon",

note = "Funding Information: JKS received funding from NIH T32 CA009207. AD received funding from NIH P30 CA008748.",

year = "2017",

language = "English",

volume = "4",

pages = "23--24",

journal = "Oncoscience",

issn = "2331-4737",

publisher = "Impact Journals LLC",

number = "3-4",

}

TY - JOUR

T1 - Targeting RET-rearranged lung cancers with multikinase inhibitors

AU - Sabari, Joshua K.

AU - Siau, Evan D.

AU - Drilon, Alexander

N1 - Funding Information: JKS received funding from NIH T32 CA009207. AD received funding from NIH P30 CA008748.

PY - 2017

Y1 - 2017

KW - BLU-667

KW - Cabozantinib

KW - LOXO-292

KW - Non-small cell lung cancer

KW - RET

KW - RXDX-105

KW - Tyrosine kinase inhibitor

KW - Vandetanib

UR - https://www.scopus.com/pages/publications/85019721361

M3 - Editorial

AN - SCOPUS:85019721361

SN - 2331-4737

VL - 4

SP - 23

EP - 24

JO - Oncoscience

JF - Oncoscience

IS - 3-4

ER -